Logo image
Surface modification of PLGA microspheres for targeting
Conference proceeding

Surface modification of PLGA microspheres for targeting

J.D Lathia, D El-Sherif, N.O Dhoot and M.A Wheatley
Proceedings of the IEEE 28th Annual Northeast Bioengineering Conference (IEEE Cat. No.02CH37342), v 2002-, pp 225-226
2002

Abstract

Biomedical engineering Biomedical imaging Cells (biology) Chemical engineering Drug delivery Peptides Sequences Targeted drug delivery Ultrasonic imaging Vehicles
RGD peptide was conjugated to hollow microspheres to develop PLGA ultrasound contrast agents that enhance ultrasound imaging. The microcapsules were coated with an RGD peptide that targets integrins specific to angiogenesis, /spl alpha/v/spl beta/3 and /spl alpha/v/spl beta/5. The microcapsules were then bound to rat neuroblastoma cells in vitro within 6 hours. The RGD peptide modified microcapsules makes them ideal candidates for targeted therapeutic imaging and drug delivery vehicles.

Metrics

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Engineering, Biomedical
Logo image